Stefanoudakis, D.; Frountzas, M.; Schizas, D.; Michalopoulos, N.V.; Drakaki, A.; Toutouzas, K.G.
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Curr. Issues Mol. Biol. 2024, 46, 2827-2844.
https://doi.org/10.3390/cimb46040177
AMA Style
Stefanoudakis D, Frountzas M, Schizas D, Michalopoulos NV, Drakaki A, Toutouzas KG.
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Current Issues in Molecular Biology. 2024; 46(4):2827-2844.
https://doi.org/10.3390/cimb46040177
Chicago/Turabian Style
Stefanoudakis, Dimitrios, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki, and Konstantinos G. Toutouzas.
2024. "Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer" Current Issues in Molecular Biology 46, no. 4: 2827-2844.
https://doi.org/10.3390/cimb46040177
APA Style
Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G.
(2024). Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Current Issues in Molecular Biology, 46(4), 2827-2844.
https://doi.org/10.3390/cimb46040177